Examples of 'tyrosine kinase inhibitors' in a sentence
Meaning of "tyrosine kinase inhibitors"
Tyrosine kinase inhibitors are a type of medication that specifically target and inhibit the activity of tyrosine kinases, which are enzymes involved in the regulation of cell growth and division. These inhibitors are commonly used in cancer treatment
How to use "tyrosine kinase inhibitors" in a sentence
Basic
Advanced
tyrosine kinase inhibitors
Preferred tyrosine kinase inhibitors include indolocarbazoles.
Certain compounds have been shown to be tyrosine kinase inhibitors.
Tyrosine kinase inhibitors in cancer therapy.
And receptor tyrosine kinase inhibitors.
Tyrosine kinase inhibitors are a type of growth factor inhibitor therapy.
Various amino pyrazole tyrosine kinase inhibitors have been reported.
Iclusig belongs to a group of medicines called tyrosine kinase inhibitors.
Most tyrosine kinase inhibitors.
Also provided herein are methods of making tyrosine kinase inhibitors.
The discovery of tyrosine kinase inhibitors revolutionized the treatment of chronic myelogenous leukemia.
Some quinazoline compounds have been disclosed as tyrosine kinase inhibitors.
Prominent examples are the tyrosine kinase inhibitors imatinib and gefitinib.
Methods and compositions for increasing sensitivity to tyrosine kinase inhibitors.
The present invention seeks to provide tyrosine kinase inhibitors having potent antiproliferative properties.
Hypertension and heart failure with treatment with tyrosine kinase inhibitors.
See also
Various tyrosine kinase inhibitors suitable for use in this invention are known in the art.
Development of a new therapeutic class called tyrosine kinase inhibitors is in full expansion.
Tyrosine kinase inhibitors thus may lead to the development of new treatments for pancreatic cancer.
A number of small molecules which act as tyrosine kinase inhibitors have been identified.
Several tyrosine kinase inhibitors are more or less specific for Abl.
These mutations provide therapeutic targets for several tyrosine kinase inhibitors.
Efforts to use tyrosine kinase inhibitors in AML continue.
Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors.
Pyrrolotriazine compounds useful as tyrosine kinase inhibitors are disclosed in US patent application Serial No.
Any of the compounds of the present disclosure are useful as tyrosine kinase inhibitors.
Certain bruton 's tyrosine kinase inhibitors are commercially available.
One of skill in the art will know of other tyrosine kinase inhibitors.
Tyrosine kinase inhibitors and proteasome inhibitors are examples of small-molecule drugs.
Some patients may be able to discontinue tyrosine kinase inhibitors and remain in remission.
Those based upon phosphotyrosine have been demonstrated to be the more specific tyrosine kinase inhibitors.
These mutations tend to increase sensitivity to tyrosine kinase inhibitors including gefitinib and erlotinib.
Perhaps the most promising drugs for treating fibrosis are the PDGF receptor tyrosine kinase inhibitors.
Moreover, tyrosine kinase inhibitors have the potential for limited specificity.
They have drawn much attention after the development of tyrosine kinase inhibitors.
Tyrosine kinase inhibitors such as dasatinib and nilotinib, also vincristine and vinblastine.
There is still controversy regarding its clinical relevance in the tyrosine kinase inhibitors era.
Drugs called tyrosine kinase inhibitors ( TKIs ) are generally successful at controlling the cancer.
Death by apoptosis is most often observed upon effective treatment with tyrosine kinase inhibitors.
In certain embodiments, the one or more tyrosine kinase inhibitors are administered transmucosally.
Methods for predicting cardiac toxicity before and upon treatment with tyrosine kinase inhibitors.
Medication known as tyrosine kinase inhibitors ( TKIs ) are typically profitable at controlling the cancer.
There are a few reports of selective Trk tyrosine kinase inhibitors.
Evaluating statins and receptor tyrosine kinase inhibitors as a novel combinational anti-cancer therapeutic approach.
Sorafenib is an AI that belongs to the group of small molecule tyrosine kinase inhibitors.
Tyrosine kinase inhibitors used to treat non-small cell lung cancer include erlotinib and gefitinib.
The present invention provides compounds having the structure I which are VEGF receptor tyrosine kinase inhibitors.
The administration of EGF-receptor-specific tyrosine kinase inhibitors thus inhibits the proliferation of the cells.
A number of targeting therapies are being investigated, including those that use tyrosine kinase inhibitors.
The administration of EGF-receptor-specific tyrosine kinase inhibitors therefore inhibits the reproduction of the cells.
When this happens, doctors offer these people different tyrosine kinase inhibitors.
You'll also be interested in:
Examples of using Inhibitors
Show more
It is not uncommon to have inhibitors placed in a clone
Inhibitors add challenges to the treatment of hemophilia
Neurotoxins and enzyme inhibitors associated with
Examples of using Kinase
Show more
Creatine kinase can be checked if myalgias develop
Blood tests show elevated creatine kinase
Elevation of creatine kinase in blood is indicative of myositis
Examples of using Tyrosine
Show more
Tyrosine must be determined in hydrolysates of unoxidised samples
The protein possesses tyrosine kinase activity
Tyrosine hydroxylase can also be regulated by inhibition
